SEARCH
Bharat Biotech's Covaxin granted emergency use approval for kids aged 2-18 years
India Today
2021-10-12
Views
1.1K
Description
Share / Embed
Download This Video
Report
The Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x84syvz" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
01:49
Bharat Biotech’s Covid-19 vaccine Covaxin gets WHO’s emergency use approval | Oneindia News
01:51
Bharat Biotech's Covaxin gets SEC approval for emergency use_ Sources
04:11
No emergency use approval for Bharat Biotech's Covaxin in US, FDA seeks more info & data
02:07
US drug regulator rejects emergency use approval for Bharat Biotech’s Covaxin
04:09
India Approves Two COVID-19 Vaccines: Oxford-Serum Institute's Covishield & Bharat Biotech's Covaxin Receives Emergency Approval From DCGI
01:25
Covaxin Emergency Use:India approves Serum-Oxford, Bharat Biotech's COVID vaccines for Emergency Use
01:22
Congress raises concerns over approval given to Bharat Biotech's Covaxin vaccine| Oneindia News
02:57
Why Does Bharat Biotech's Covaxin Need WHO's Approval?
01:59
Bharat Biotech’s Covaxin To Get WHO’s Approval Soon, Says IFS Harsh Vardhan Singla
04:13
Bharat Biotech's Covaxin gets WHO approval
07:19
Bharat Biotech's Covaxin on the brink of WHO approval
01:56
Bharat Biotech’s Covaxin Set For Trials on Children Aged Between 2 -18
